Thromboelastography in dogs with idiopathic epilepsy treated with phenobarbital monotherapy
Veterinary Clinical Pathology · 2024
DOI: 10.1111/vcp.13380 ↗Kurz gefasst
Fachartikel in der Zeitschrift Veterinary Clinical Pathology, 2024. Verfasst von R García und 3 weiteren Autor:innen. Beteiligte Einrichtung: Servei de Neurologia, Fundació Hospital Clínic Veterinari, Campus Universitat Autònoma de Barcelona, Bellaterra, Spain. Hauptthemen laut MEDLINE: Thrombelastography, Phenobarbital, Dog Diseases, Epilepsy. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Thromboelastography (TEG) is an effective technique to assess the efficiency of coagulation. Phenobarbital (PB) can induce hematological and coagulation disorders in both animals and humans, but its effects on hemostasis have been little investigated and are poorly understood in dogs.
Objectives
The aim of this article was to assess coagulation using TEG in a population of dogs with idiopathic epilepsy treated with PB. Material and Methods Prospective observational study. TEG was performed in blood samples from dogs with idiopathic epilepsy that were divided in three groups: Two groups of treated dogs that were on phenobarbital treatment for less or more than 6 months, and a control group of healthy dogs. Duration of treatment, dose, phenobarbital serum concentration and selected hematological and biochemical parameters were evaluated and correlated with the TEG results.
Results
No statistically significant differences were found between groups. None of the animals appeared to be in a hypo‐ or hypercoagulable state, however 9/19 (47,4%) dogs were classified as hyper‐fibrinolytic. A statistically significant negative relationship between MA and G values and increased fibrinolytic activity (LY30) were found. No statistically significant relationship was found between PB dose or PB blood levels and TEG parameters in either group. No bleeding complications were observed.
Discussion
The rise in fibrinolysis might be due to hepatic damage from PB, as indicated by elevated liver enzymes in many dogs with abnormal fibrinolytic patterns. Although TEG showed hyperfibrinolysis in some dogs, the presence of primary or secondary hyperfibrinolysis could not be confirmed due to the lack of D‐dimer measurements and liver biopsy. TEG’s sensitivity compared to other fibrinolysis biomarkers like PAP might also affect results.
Conclusions
TThe cause of hyperfibrinolysis in epileptic dogs treated with phenobarbital remains unclear, with potential links to hepatic effects or handling, and further research is needed to assess its clinical significance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Servei de Neurologia, Fundació Hospital Clínic Veterinari, Campus Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Departament de Medicina i Cirurgia Animal, Facultat de Veterinària, Edifici V, Universitat Autònoma de Barcelona, Bellaterra, Spain.
- Servei d'Hematologia Clínica Veterinària, Facultat de Veterinària, Edifici V, Universitat Autònoma de Barcelona, Bellaterra, Spain.
Zitieren
APA
García, R., Pastor, J., de la Fuente, C., & Añor, S. (2024). Thromboelastography in dogs with idiopathic epilepsy treated with phenobarbital monotherapy. Veterinary Clinical Pathology. https://doi.org/10.1111/vcp.13380
Vancouver
García R, Pastor J, de la Fuente C, Añor S. Thromboelastography in dogs with idiopathic epilepsy treated with phenobarbital monotherapy. Veterinary Clinical Pathology. 2024. doi:10.1111/vcp.13380
BibTeX
@article{Garca2024,
author = {García, R and Pastor, J and de la Fuente, C and Añor, S},
title = {Thromboelastography in dogs with idiopathic epilepsy treated with phenobarbital monotherapy},
journal = {Veterinary Clinical Pathology},
year = {2024},
doi = {10.1111/vcp.13380}
}
EUVIMED